Short sleep duration is associated with an increased risk of cardiovascular disease and all-cause mortality, although a relationship with atherosclerosis in the elderly remains unclear.
A previous epidemiological study demonstrated that short sleep duration significantly increased the risk of all-cause mortality. 1 Compared with a typical duration of 8 h, 5 h or less of sleep was associated with heart disease, 2 and the odds ratio for cardiovascular disease was 2.20 with <5 h. 3 Short sleep duration is also linked to increased risks of diabetes 4 and hypertension, 5 and may be a significant risk factor for high cholesterol. 6 Cross-sectional associations were found between shorter sleep durations and lower high-density lipoprotein cholesterol levels in American women with type 2 diabetes 7 and Japanese women from the general population. 8 There is growing evidence that less sleep could be a primary risk factor for atherosclerosis; therefore, it is clinically important to assess any morphological and physiological changes in the vasculature associated with sleep duration.
Although mechanisms that connect short sleep duration to the metabolic syndromes are unknown, sleep deprivation does lead to impaired glucose tolerance, higher evening cortisol levels, and increased sympathetic activity in healthy subjects. 9 Current data also suggest a relationship between sleep restriction, weight gain, and diabetes risk that involves at least three pathways: altered glucose metabolism, upregulated appetite, and decreased energy expenditure. 10 Extreme sleep habits may also activate pro-inflammatory pathways that affect health. 11 Insomnia is a highly prevalent, often debilitating, and economically burdensome form of sleep disturbance caused by various situational, medical, emotional, environmental, and behavioral factors. Moreover, insomnia with objectively measured short sleep duration was associated with increased mortality. 12 Insomnia coupled with <6 h of sleep increased the risk of hypertension, 13 type 2 diabetes, 4 hypercortisolemia, catecholaminergic activity, and autonomic activity that could lead to cardiovascular disease. 14, 15 A recent population study demonstrated that insomnia was associated with moderately increased risk of acute myocardial infarction. 16 Nearly all epidemiological studies reported an increased prevalence of insomnia symptoms with age, reaching 50% in elderly individuals. 17 There are strong associations between insomnia original contributions Short Sleep and Atherosclerosis in the Elderly and impaired quality of life for the elderly; however, vascular changes related to insomnia have not been fully investigated.
Our aim for this study was to determine whether short sleep duration and insomnia are associated with atherosclerosis in the elderly.
Methods
Study population. Eighty-six volunteers aged ≥65 years (mean, 73.6 ± 4.9 years; 25 male, 61 female) were recruited from spring 2009 to spring 2010. Five were excluded due to insufficient data. Subjects provided information on age and health such as alcohol use, smoking status, physical activity, history of hypertension, diabetes mellitus, and hyperlipidemia. The Nagoya University and Chubu University Ethics Review Committees approved all study procedures, and subjects provided written informed consent to participate.
Covariate assessments. Height and weight were measured to calculate body mass index. Hypertension was defined as diastolic blood pressure (DBP) ≥90 mm Hg, systolic blood pressure (SBP) ≥140 mm Hg, or self-reported usage of antihypertensive medication. Hyperlipidemia was defined as having high blood lipid concentrations, including highdensity lipoprotein cholesterol ≤40 mg/dl, low-density lipoprotein cholesterol ≥140 mg/dl, triglycerides ≥150 mg/ dl, or self-reported treatment for hyperlipidemia. Diabetes was defined as a fasting glucose level ≥126 mg/dl, a nonfasting glucose level ≥200 mg/dl, a self-reported diagnosis, or current use of anti-diabetic medication. Current smokers were defined as subjects who reported recent cigarette use, and current drinkers were defined as subjects who reported consumption of at least one alcoholic beverage 30 days before the study. The symptoms in insomnia was defined by a complain of difficulty initiating sleep, difficulty maintaining sleep, or waking up too early or sleep that is chronically nonrestorative or poor in quality based on the International Classification of Sleep Disorders. 18 The insomnia is present for at least 1 month. The patient has evidence of conditioned sleep difficulty and/or heightened arousal in bed. Sleep-onset latency or wake time after sleep onset usually exceed 30 min.
Subjective sleep measurements. Subjective sleep symptoms, disturbances, and patterns were assessed using the Pittsburgh Sleep Quality Index (PSQI). 19 Responses to 19 questions were categorized into seven component scores (subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction) and then combined to create a global score. Global scores ranged from 0 to 21, with higher scores indicating a sleep disorder. 8 Daytime sleepiness was quantified using the Epworth Sleepiness Scale, which measures sleep propensity in eight standardized daily situations. Total scores ranged from 0 to 24, with higher scores reflecting greater sleepiness. 20 Excessive daytime sleepiness was defined as Epworth Sleepiness Scale ≥11.
Actigraphy. Total sleep time (TST) and sleep efficiency (as calculated TST divided by the time spent in bed) were measured by actigraphy, 21 which provides a suitable objective measurement of sleep quantity. 22 Subjects wore an actigraph (AMI, Ambulatory Monitoring, Ardsley, NY) to monitor the occurrence and extent of motion and store data as activity counts in 1-min increments.
Sleep apnea measurements. Sleep apnea was evaluated overnight with a portable home monitoring system (Apnomonitor III: CHEST, Tokyo, Japan). The apnea-hypopnea index (AHI, per hour), oxygen desaturation index (per hour), and lowest arterial oxyhemoglobin saturation point (lowest SpO 2 ) were calculated for each subject. Sleep apnea syndrome was diagnosed based on the International Classification of Sleep Disorders. 18 Carotid intima-media thickness measurements. Atherosclerosis was evaluated by measuring carotid artery intima-media thickness (IMT) 23 and plaque score. 24 Atherosclerotic changes were measured with a B-mode ultrasound and 7.5-MHz linear probe. Maximum IMT for the common and internal carotid arteries was defined as the mean of the left and right side maximum IMT.
Echocardiography. Standard echocardiography, including measurement of transmitral flow velocity indexes, was performed. The left ventricular (LV) end-diastolic dimension, LV end-systolic dimension, interventricular septal thickness, and LV posterior wall thickness were measured with twodimensional echocardiography, and the LV ejection fraction was calculated. Peak early and late transmitral filling velocities, their ratios, and the deceleration time of peak E velocity were measured from mitral inflow velocities. LV mass was measured according to the 2005 American Society of Echocardiography Guidelines. 25 Statistical analysis. Subjects were categorized on the basis of insomnia, AHI, and TST (≤5 h, >5-7 h, and >7 h); continuous variables were presented as mean ± SD. Regression diagnostics including normality, linearity, and multicollinearity were assessed. ANOVA, unpaired Student's t-tests or the χ 2 test was used to evaluate intergroup comparisons. Spearman's correlation coefficient was used for correlation analyses. Multivariate regression analysis was performed to determine independent association of IMT with age, body mass index, TST, sleep efficiency, PSQI, AHI, SBP, DBP, sex, hypertension, hyperlipidemia, diabetes mellitus, sleep apnea syndrome, and insomnia. All analyses were performed using statistical software (Statview for Windows version 4.54, SAS Institute; Cary, NC). P < 0.05 was considered statistically significant. 11.3%, P = 0.03, respectively), with no significant differences in hypertension, diabetes, hyperlipidemia, smoking, or alcohol consumption ( Table 1 ). There were no significant differences in echocardiographic findings, PSQI, AHI, oxygen desaturation index, or lowest SpO 2 among the three groups.
Insomnia complaints were reported for 38.4% (33/86) of subjects (men, 40.0%; women, 37.7%). IMT and plaque score were significantly greater in the insomnia group than the noninsomnia group (1.3 ± 0.5 vs. 1.1 ± 0.4 mm, P = 0.03; 1.8 ± 1.7 vs. 1.1 ± 1.4, P = 0.03, respectively) ( Table 2 ). There were no significant differences in AHI or echocardiographic findings between the two groups.
There were no significant differences in cardiovascular parameters between subjects with AHI ≥15/h and those with AHI <15/h. Oxygen desaturation index was significantly higher and the lowest SpO 2 significantly lower in subjects with AHI ≥15/h than those with AHI <15/h (5.6 ± 4.8/h vs. 2.2 ± 2.2/h, P < 0.001; 80.8 ± 5.9 vs. 87.7 ± 4.3%, P < 0.001, respectively) ( Table 3) .
IMT was significantly correlated with SBP, DBP, and TST (SBP: r = 0.49, P < 0.0001; DBP: r = 0.33, P = 0.0021; TST: r = −0.28, P = 0.010). Multiple regression analysis revealed that SBP, TST, and the PSQI were significant contributing factors for increased IMT (SBP: coefficient β = 0.56, P = 0.0001; TST: coefficient β = −0.32, P = 0.005; PSQI: coefficient β = 0.22, P = 0.05) ( Table 4) . IMT was significantly greater in insomnia or TST ≤5 h group and insomnia and TST ≤5 h group than in noninsomnia and TST >5 h group. Plaque score was significantly greater in insomnia and TST ≤5 h group than in noninsomnia and TST >5 h group ( Table 5) . Data are presented as mean ± SD unless otherwise indicated. AHI, apnea-hypopnea index; BMI, body mass index; BSA, body surface area; DBP, diastolic blood pressure; DcT, deceleration time of peak E velocity; E/A, peak early systolic velocity/atrial contraction velocity; IMT, intima-media thickness; IVST, interventricular septal thickness; lowest SpO 2 , lowest arterial oxyhemoglobin saturation; LVDd, left ventricular end-diastolic dimension; LVDs, left ventricular end-systolic dimension; LVEF, left ventricular ejection fraction; LVPWT, left ventricular posterior wall thickness; ODI, oxygen desaturation index; PSQI, Pittsburgh Sleep Quality Index; SBP, systolic blood pressure. *P < 0.05 vs. >7 h, † P < 0.05 vs. 5-7 h original contributions
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discussion
In the present study, we found that IMT was significantly greater in subjects with insomnia or a TST ≤5 h and was significantly correlated with SBP, DBP, and TST. Although SBP, TST, and PSQI were factors significantly associated with increased IMT, AHI was not. These results suggest that high blood pressure, short sleep duration, and poor sleep quality are independently associated with atherosclerosis in the elderly. This study revealed a significant correlation between IMT and TST. Short sleep duration has been shown to be an independent risk factor for hypertension, 5 associated with higher nocturnal catecholamine concentrations 26 and altered interleukin-6 levels. 27 Hypertensive subjects demonstrated significant increases in blood pressure and sympathetic activity following nights of restricted sleep time. 28 Short sleep duration has also been shown to increase the risk of myocardial infarction in women. 2 However, sleep duration was not significantly correlated with blood pressure in our study. Previous studies were unable to find associations between sleep duration and hypertension in the elderly, 29, 30 which is consistent with our results. Advance age is associated with changes in sleep architecture with increased difficulties in sleep initiation and maintenance. Clinical observations suggest that loss of sleep and sleep disorder with decreases in slow wave sleep may serve to elevate nocturnal catecholamine original contributions
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levels and contribute to cardiovascular disease in young and middle-aged healthy male volunteers, 26 whereas total sleep time during the night and slow wave sleep are reduced, and sleep efficiency falls with an increase in the number of awakening in the elderly. In condition such as aging and depression, where there is a relative increase in rapid eye movement sleep at the expense of slow wave sleep, it is possible that abnormal increases in interleukin-6 may occur during sleep, with implications for inflammatory and cardiovascular disease risk in these population. 27 Short sleep duration is also associated with obesity in younger subjects than in elderly subjects, and sleep apnea/hypopnea increase with age. Moreover, although left ventricular hypertrophy is an independent risk factor for subclinical atherosclerosis in young to middle-aged individuals, 31 LV mass/body surface area was not related to IMT in the present study, which only included elderly subjects (>65 years). IMT reportedly increases with age, 32 whereas LV mass/body surface area does not. 33 These age-related changes may help explain our observations in the elderly population. Short-term sleep deprivation leads to increased sympathetic nervous system activity, elevated blood pressure, impaired glucose tolerance, and increased inflammatory markers, which may reflect and increase the risk of cardiovascular disease. The Study of Health in Pomerania demonstrated that short self-reported sleep duration was associated with higher IMT in participants aged 20-79 years. 34 A recent study on 24-h ambulatory blood pressure in middle-aged adults with untreated high clinic blood pressure demonstrated that poor sleep quality was associated with blunted blood pressure dipping i.e., a predictor of adverse cardiovascular outcomes. 35 The Atherosclerosis Risk in Communities study suggested that small artery remodeling is a preceding risk factor for hypertension. 36 Our findings indicate that short sleep duration (≤ 5 h), poor sleep quality, and high blood pressure could influence atherosclerosis in the elderly. The combination of these factors might promote atherosclerosis.
The present study also found that IMT was significantly greater in insomnia group than in noninsomnia group. Difficulty maintaining sleep, or sleep that is chronically nonrestorative or poor in quality in insomnia may play an important role in the autonomic nervous system during sleep, resulting in the development of atherosclerosis. Insomnia has been associated with cardiovascular disease outcomes, 16 but its role in all-cause mortality remains unknown. Combined with short sleep duration, it has a high risk of hypertension comparable with other common sleep disorders. 14 We showed that insomnia with short sleep duration is associated with high plaque score. Insomnia is also associated with the nocturnal original contributions
elevation of circulating norepinephrine and a reduction in natural killer cell activity, which supports the role of sleep in regulating sympathetic nervous and immune system function. Chronic insomnia is connected to increased adrenocorticotropic hormone and cortisol levels, which indicates increased activity in the hypothalamic-pituitary-adrenal axis. 17 Short sleep and sleep deprivation affects increases in sympathetic activity, acting directly or in combination with inflammatory, elevated cortisol levels, unhealthy behavior, or metabolic disturbances. 9, 10 Future studies should evaluate the potential interaction between short sleep and insomnia, whether either causes the other, and if so, which of these is actually related to the development of atherosclerosis. Given the importance of early atherosclerosis detection for preventing complications, insomnia management may be clinically beneficial. We found no significant relationship between the AHI and IMT, with TST and the PSQI contributing to increased IMT instead. Sleep apnea and intermittent hypoxia are associated with the early vascular changes that trigger atherosclerosis. 37 Obstructive sleep apnea syndrome (OSAS) is recognized as a secondary cause of hypertension and may contribute to insulin resistance, diabetes, and dyslipidemia, which are well established risk factors for atherosclerosis. Moreover, OSAS can have direct proatherogenic effects, including systemic inflammation, oxidative stress, vascular smooth cell activation, increased adhesion molecule expression, monocyte/lymphocyte activation, increased lipid loading in macrophages, lipid peroxidation, and endothelial dysfunction. 38 We previously demonstrated that repeated arousal of middle-aged patients with OSAS was related to endothelial dysfunction 39 and the AHI was not the sole determinant for OSAS prognosis in the elderly. 40 Although sleep-disordered breathing is common in the geriatric population, the effects of aging on clinical apnea and hypopnea have not been adequately investigated. Results from this study suggest two distinct types of elderly patients with OSAS and frequent apnea/hypopnea, those with moderate to severe oxygen desaturation and those with mild oxygen desaturation. There is some support for this distinction in a report from Bliwise et al. 41 with two age-related conditions for sleep apnea, one in the middle-aged population and one among the elderly. The contribution of frequent apnea/hypopnea to uniform cardiovascular risk may not exist with elderly patients. Although the AHI can be an index of OSAS severity, nocturnal oxygen desaturation and arousal are also closely related to atherosclerosis. Vascular changes were not explained by the AHI alone, and thus sleep time and sleep quality may play important roles in atherosclerosis development in the elderly.
study liMitations
Our study has several limitations. First, it was difficult to observe sex/age differences due to the limited number of men, although sex/age difference was not significantly independent factor associated with increased IMT in our study. Women tend to have more sleep-related complaints and a greater risk of insomnia than men. 42 Shortened sleep time (<6 h) also produced a higher risk of hypertension for women 43 than men and was associated with increased female mortality from coronary heart disease. 2 In addition, the relationship between short sleep duration and high cholesterol continued to be statistically significant in women but not men after controlling for confounding variables and mediating influences. 6 Recent national sample study showed that the association between hours of sleep and hypertension varies with age and sex. 44 The present study population comprised relatively older subjects. Further evaluation in a large study is needed to clarify these points.
Second, we failed to find any significant associations between sleep efficiency and IMT, even though the PSQI was related to IMT. The validity of actigraphic sleep assessment was supported by the significant correlation of its recorded TST and sleep efficiency to polysomnography measurements in patients with insomnia. 21 A previous study reported that insomnia, poor sleep, or objectively measured short sleep duration alone did not have a clinically relevant impact on hypertension risk, 12, 13 while insomnia or poor sleep combined with short sleep duration was associated with clinically significant risk. Patients with insomnia tend to have sleep difficulty and/ or hightened arousal in bed. The PSQI evaluated sleep quality, sleep latency, sleep time, sleep difficulty, and daytime sleepiness for 1 month. Findings from our subjective and objective sleep parameters suggest that the PSQI is useful information for elderly patients at risk of atherosclerosis. Further studies are needed to establish relationships between subjective and objective sleep parameters and atherosclerosis in the elderly.
Finally, we evaluated sleep apnea with portable home monitoring systems. Sleep laboratory test is not necessary to evaluate and diagnose most forms of insomnia, with the exception of sleep apnea or restless legs/periodic limb movements. Polysomnographic measurements may provide a pathophysiological explanation for the connection between sleep parameters and atherosclerosis in the elderly.
Objectively measured SBP, poor sleep, short sleep duration, and insomnia were associated with increased IMT and may therefore contribute to atherosclerosis in the elderly. These results confirm and explain findings from previous studies that link sleep duration to cardiovascular disease and call attention to the important role insomnia or sleep quality could play in the promotion of atherosclerosis.
